These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 932999)

  • 41. Study of the sites and mechanisms of action of bumetanide in man.
    Jayakumar S; Puschett JB
    J Pharmacol Exp Ther; 1977 Apr; 201(1):251-8. PubMed ID: 850144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disposition of bumetanide in the isolated perfused rat kidney: effects of probenecid and dose response.
    Bekersky I; Popick AC
    Am J Cardiol; 1986 Jan; 57(2):33A-37A. PubMed ID: 3946203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostaglandin/kinin activity related to changed renal compliance after bumetanide in dogs.
    Olsen UB
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):430-8. PubMed ID: 576566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrolyte excretion patterns. Intravenous and oral doses of bumetanide compared to furosemide.
    Brater DC; Fox WR; Chennavasin P
    J Clin Pharmacol; 1981; 21(11):599-603. PubMed ID: 7338569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute diuretic effect of continuous intravenous infusion of an aqueous extract of Coriandrum sativum L. in anesthetized rats.
    Aissaoui A; El-Hilaly J; Israili ZH; Lyoussi B
    J Ethnopharmacol; 2008 Jan; 115(1):89-95. PubMed ID: 17961943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
    Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacology of bumetanide.
    Frey HH
    Postgrad Med J; 1975; 51 Suppl 6():14-18. PubMed ID: 1197201
    [No Abstract]   [Full Text] [Related]  

  • 50. Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):424-34. PubMed ID: 8873690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.
    Ward A; Heel RC
    Drugs; 1984 Nov; 28(5):426-64. PubMed ID: 6391889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mode of action of bumetanide: inhibition of chloride transport across the amphibian cornea.
    McGahan MC; Yorio T; Bentley PJ
    J Pharmacol Exp Ther; 1977 Oct; 203(1):97-102. PubMed ID: 409836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and diuretic effect of bumetanide following intravenous and intramuscular administration to horses.
    Delbeke FT; Debackere M; Desmet N; Stevens M
    J Vet Pharmacol Ther; 1986 Sep; 9(3):310-7. PubMed ID: 3761422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of bumetanide in nephrotic syndrome: a double-blind crossover study with furosemide.
    Lau K; DeFronzo R; Morrison G; Rascoff J; Goldberg M; Agus ZS
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):489-97. PubMed ID: 789411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of ozolinone, a diuretic active metabolite of etozoline, on renal function. I. Clearance studies in dogs.
    Greven J; Heidenreich O
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):283-7. PubMed ID: 714186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of the urinary metabolites of 14C-bumetanide in the rat and their excretion by rats and dogs.
    Kolis SJ; Williams TH; Schwartz MA
    Drug Metab Dispos; 1976; 4(2):169-76. PubMed ID: 5262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loop-diuretic inhibition of adrenaline-stimulated Cl- secretion in a cultured epithelium of renal origin (MDCK).
    Brown CD; Rugg EL; Simmons NL
    Q J Exp Physiol; 1986 Apr; 71(2):183-93. PubMed ID: 3714958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bumetanide and furosemide in heart failure.
    Brater DC; Day B; Burdette A; Anderson S
    Kidney Int; 1984 Aug; 26(2):183-9. PubMed ID: 6503136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of intravenous bumetanide administration on renal haemodynamics and proximal and distal tubular sodium reabsorption in conscious rats.
    Shalmi M; Petersen JS; Christensen S
    Pharmacol Toxicol; 1989 Oct; 65(4):313-7. PubMed ID: 2587512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal effects of the high ceiling diuretic torasemide in rats and dogs.
    Ghys A; Denef J; Delarge J; Georges A
    Arzneimittelforschung; 1985; 35(10):1527-31. PubMed ID: 4074408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.